Trulieve Cannabis is trading at $11.15, down -10.18%, after the September 29 regular-session close; no clear company-specific catalyst was identified.
- The Connected licensing announcement for Alien Labs and Connected products in Florida and Texas was reported September 28; available coverage does not link it to the decline.
- Supplied broad-market indicators were mixed and modest, so they do not establish a market-wide explanation; the move remains unexplained.